Ricker R, Perea Lopez N, Terrones M, Loew M, Ghedi. Rapid and label-free influenza A virus subtyping using surface-enhanced Raman spectroscopy with incident-wavelength analysis. Biomed Opt Express. 2024 Aug 7;15(9):5081-5097.
Early virus identification is a key component of both patient treatment and epidemiological monitoring. In the case of influenza A virus infections, where the detection of subtypes associated with bird flu in humans could lead to a pandemic, rapid subtype-level identification is important. Surface-enhanced Raman spectroscopy coupled with machine learning can be used to rapidly detect and identify viruses in a label-free manner. As there is a range of available excitation wavelengths for performing Raman spectroscopy, we must choose the best one to permit discrimination between highly similar subtypes of a virus. We show that the spectra produced by influenza A subtypes H1N1 and H3N2 exhibit a higher degree of dissimilarity when using 785 nm excitation wavelength in comparison with 532 nm excitation wavelength. Furthermore, the cross-validated area under the curve (AUC) for identification was higher for the 785 nm excitation, reaching 0.95 as compared to 0.86 for 532 nm. Ultimately, this study suggests that exciting with a 785 nm wavelength is better able to differentiate two closely related influenza viruses and likely can extend to other closely related pathogens.
See Also:
Latest articles in those days:
- Characterisation of a human monoclonal antibody targeting a conserved epitope at the base of the HA head of influenza A(H3N2) virus 5 hours ago
- An outbreak report of Influenza A(H3) among residents of a large nursing home in northern Italy: attack rates, clinical features and outcomes 18 hours ago
- Susceptibility of calves fed unpasteurized milk from cows infected with highly pathogenic avian influenza H5N1 18 hours ago
- Functional mapping of IFITM3 resolves its antiviral core and deciphers human influenza susceptibility 18 hours ago
- Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection 18 hours ago
[Go Top] [Close Window]


